Sex-Based Disparities in the Transition to Dolutegravir-Based Antiretroviral Therapy in West African HIV Cohorts - HAL Accéder directement au contenu
Article dans une revue Open Forum Infectious Diseases Année : 2024

Sex-Based Disparities in the Transition to Dolutegravir-Based Antiretroviral Therapy in West African HIV Cohorts

Résumé

Transition to dolutegravir among 21 167 individuals experienced in antiretroviral therapy in West Africa showed heterogeneous timelines and patterns. Initially reported sex disparities tended to catch up over time with persisting disparities, according to contributing HIV clinics. Key factors facilitating dolutegravir switch were male sex, age <50 years, viral suppression, and regimens not based on protease inhibitors.
Fichier principal
Vignette du fichier
BPH_OpenForumInfectDis_2024_Tiendrebeogo.pdf ( 594.02 Ko ) Télécharger
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-04625804, version 1 (26-06-2024)

Licence

Paternité - CC BY 4.0

Identifiants

Citer

Thierry Tiendrebeogo, Karen Malateste, Armel Poda, Albert Minga, Eugene Messou, et al.. Sex-Based Disparities in the Transition to Dolutegravir-Based Antiretroviral Therapy in West African HIV Cohorts. Open Forum Infectious Diseases, 2024, 11 (5), pp.ofae139. ⟨10.1093/ofid/ofae139⟩. ⟨hal-04625804⟩

Collections

IRD U1219
0 Consultations
0 Téléchargements
comment ces indicateurs sont-ils produits

Altmetric

Partager

Gmail Facebook Twitter LinkedIn Plus